Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Goat Polyclonal Antibody against ABCC4
| Applications | IHC, WB |
| Reactivities | Human, Rat (Expected from sequence similarity: Mouse) |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CNGQPSTLTIFETAL, from the C Terminus of the protein sequence according to NP_005836.2. |
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Goat Anti-CD20 / MS4A1 (C Terminus) Antibody
| Applications | IHC, PEP-ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CQDQESSPIENDSSP, from the C Terminus of the protein sequence according to NP_068769.2; NP_690605.1. |
Goat Polyclonal Anti-CD19 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 510 aa to the C-terminus of human CD19 produced in E. coli. |
Goat Polyclonal Anti-VEGFR2 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from the N-terminus (residues 20-125 aa) of human VEGFR2 produced in E. coli. |
Goat Polyclonal Antibody against ITGAM
| Applications | IHC, WB |
| Reactivities | Human (Expected from sequence similarity: Mouse, Rat, Dog) |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-RNDGEDSYRTQ, from the internal region of the protein sequence according to NP_000623.2. |
Active filters
Antibody Hosts
- Goat
Clonalities
- Polyclonal
Families
- Transmembrane
Availabilities
- In Stock
Filter by
Category
Target Symbol
- CALNEXIN (3)
- GJA1 (3)
- CAVEOLIN 1 (2)
- CD19 (2)
- CD45 (2)
- CD63 (2)
- E CADHERIN (2)
- OB CADHERIN (2)
- ABCB5 (1)
- AMINOPEPTIDASE A (1)
- ANGIOTENSIN II TYPE 1 RECEPTOR (1)
- APOLIPOPROTEIN L 1 (1)
- ATP6IP2 (1)
- B3GNT1 (1)
- BAK (1)
- BAX (1)
- BDKRB1 (1)
- BMPR1A (1)
- BOC (1)
- CACNA1C (1)
- CANNABINOID RECEPTOR I (1)
- CAVEOLIN 2 (1)
- CAVEOLIN 3 (1)
- CD11B (1)
- CD2 (1)
- CD20 (1)
- CD31 (1)
- CD4 (1)
- CHRM1 (1)
- CHRNA5 (1)
- COMT (1)
- CPT1C (1)
- CRLS1 (1)
- CYBB (1)
- DGAT1 (1)
- DNAJB9 (1)
- EGFR (1)
- EPITHELIAL SODIUM CHANNEL GAMMA (1)
- FLVCR (1)
- FRIZZLED 7 (1)
- FRIZZLED 8 (1)
- GCNT3 (1)
- GPR119 (1)
- GPR40 (1)
- GRIA4 (1)
- GRIK3 (1)
- HER2 (1)
- HRH1 (1)
- INSULIN RECEPTOR (1)
- LAT (1)
- MC2 RECEPTOR (1)
- MONOAMINE OXIDASE B (1)
- MRP4 (1)
- MRP5 (1)
- MYELIN OLIGODENDROCYTE GLYCOPROTEIN (1)
- N CADHERIN (1)
- NEURONAL MEMBRANE GLYCOPROTEIN M6 A (1)
- NOX1 (1)
- NRG3 (1)
- P75 NGF RECEPTOR (1)
- POLYCYSTIN 1 (1)
- SLC22A17 (1)
- SLC26A6 (1)
- SMOOTHENED (1)
- SNX19 (1)
- SODIUM BICARBONATE TRANSPORTER LIKE PROTEIN 11 (1)
- SYNTAXIN 6 (1)
- TAZ (1)
- TGFBI (1)
- THROMBIN RECEPTOR (1)
- TNF ALPHA (1)
- TNFRSF14 (1)
- TUSC3 (1)
- UNC5C (1)
- VANGL2 (1)
- VEGF RECEPTOR 2 (1)
- WNT4 (1)
Reactivities
Applications
Isotypes
Conjugates
Pathways
- Cell adhesion molecules (CAMs) (9)
- Neuroactive ligand-receptor interaction (9)
- Pathways in cancer (9)
- Calcium signaling pathway (8)
- Focal adhesion (7)
- Hematopoietic cell lineage (7)
- Metabolic pathways (7)
- Cytokine-cytokine receptor interaction (6)
- Adherens junction (5)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (5)
- Primary immunodeficiency (5)
- Regulation of actin cytoskeleton (5)
- T cell receptor signaling pathway (5)
- Antigen processing and presentation (4)
- Basal cell carcinoma (4)
- Bladder cancer (4)
- Colorectal cancer (4)
- Endometrial cancer (4)
- Gap junction (4)
- Leukocyte transendothelial migration (4)
- Wnt signaling pathway (4)
- ABC transporters (3)
- Endocytosis (3)
- ErbB signaling pathway (3)
- Fc gamma R-mediated phagocytosis (3)
- MAPK signaling pathway (3)
- Melanogenesis (3)
- Melanoma (3)
- Type II diabetes mellitus (3)
- Adipocytokine signaling pathway (2)
- Alzheimer's disease (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Apoptosis (2)
- B cell receptor signaling pathway (2)
- Complement and coagulation cascades (2)
- Dilated cardiomyopathy (2)
- Fc epsilon RI signaling pathway (2)
- GnRH signaling pathway (2)
- Hedgehog signaling pathway (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Lysosome (2)
- Natural killer cell mediated cytotoxicity (2)
- Neurotrophin signaling pathway (2)
- Non-small cell lung cancer (2)
- Pancreatic cancer (2)
- Pathogenic Escherichia coli infection (2)
- Prostate cancer (2)
- Renin-angiotensin system (2)
- TGF-beta signaling pathway (2)
- Thyroid cancer (2)
- Tyrosine metabolism (2)
- Vascular smooth muscle contraction (2)
- Viral myocarditis (2)
- Allograft rejection (1)
- Arginine and proline metabolism (1)
- Asthma (1)
- Axon guidance (1)
- Cardiac muscle contraction (1)
- Dorso-ventral axis formation (1)
- Drug metabolism - cytochrome P450 (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Fatty acid metabolism (1)
- Glioma (1)
- Glycerolipid metabolism (1)
- Glycerophospholipid metabolism (1)
- Glycine (1)
- Glycosphingolipid biosynthesis - lacto and neolacto series (1)
- Graft-versus-host disease (1)
- Histidine metabolism (1)
- Huntington's disease (1)
- Insulin signaling pathway (1)
- Keratan sulfate biosynthesis (1)
- Long-term potentiation (1)
- N-Glycan biosynthesis (1)
- NOD-like receptor signaling pathway (1)
- O-Glycan biosynthesis (1)
- PPAR signaling pathway (1)
- Phenylalanine metabolism (1)
- Prion diseases (1)
- RIG-I-like receptor signaling pathway (1)
- Retinol metabolism (1)
- SNARE interactions in vesicular transport (1)
- Systemic lupus erythematosus (1)
- Taste transduction (1)
- Toll-like receptor signaling pathway (1)
- Tryptophan metabolism (1)
- Type I diabetes mellitus (1)
- VEGF signaling pathway (1)
- p53 signaling pathway (1)
- serine and threonine metabolism (1)